Cargando…

Chemotherapeutic Treatments Increase PD-L1 Expression in Esophageal Squamous Cell Carcinoma through EGFR/ERK Activation

The current study reveals the clinicopathological association of PD-L1 in Hong Kong esophageal squamous cell carcinoma (ESCC) patients and the differential regulation of PD-L1 by standard first-line chemotherapy in ESCC. Immunohistochemical analysis of tissue microarray data from 84 Hong Kong ESCC p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ng, Hoi Yan, Li, Jian, Tao, Lihua, Lam, Alfred King-Yin, Chan, Kwok Wah, Ko, Josephine Mun Yee, Yu, Valen Zhuoyou, Wong, Michael, Li, Benjamin, Lung, Maria Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2018
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122398/ https://www.ncbi.nlm.nih.gov/pubmed/30172884 http://dx.doi.org/10.1016/j.tranon.2018.08.005

Ejemplares similares

A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma
por: Ip, Joseph Chok Yan, et al.
Publicado: (2015)

Corrigendum to “A Versatile Orthotopic Nude Mouse Model for Study of Esophageal Squamous Cell Carcinoma”
por: Ip, Joseph Chok Yan, et al.
Publicado: (2016)

Depletion of DNA Polymerase Theta Inhibits Tumor Growth and Promotes Genome Instability through the cGAS-STING-ISG Pathway in Esophageal Squamous Cell Carcinoma
por: Li, Jian, et al.
Publicado: (2021)

FANCD2 Confers a Malignant Phenotype in Esophageal Squamous Cell Carcinoma by Regulating Cell Cycle Progression
por: Lei, Lisa Chan, et al.
Publicado: (2020)

Gain-of-function hot spot mutant p53(R248Q) regulation of integrin/FAK/ERK signaling in esophageal squamous cell carcinoma
por: Yu, Valen Zhuoyou, et al.
Publicado: (2020)

Cylindromatosis Lysine 63 Deubiquitinase (CYLD) Regulates NF-kB Signaling Pathway and Modulates Fibroblast and Endothelial Cells Recruitment in Nasopharyngeal Carcinoma
por: Deng, Mingdan, et al.
Publicado: (2020)

Multigene Profiling of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma Identifies Prognostic Cancer Driver Genes Associated with Epithelial-Mesenchymal-Transition Progression and Chemoresistance
por: Tan, Zhen, et al.
Publicado: (2023)

Nasopharyngeal carcinoma MHC region deep sequencing identifies HLA and novel non-HLA TRIM31 and TRIM39 loci
por: Ning, Lvwen, et al.
Publicado: (2020)

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2016)

Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma
por: Ko, Josephine Mun Yee, et al.
Publicado: (2020)

Histological Regression of Squamous Esophageal Carcinoma Assessed by Percentage of Residual Viable Cells after Neoadjuvant Chemoradiation is an Important Prognostic Factor
por: Tong, Daniel King Hung, et al.
Publicado: (2010)

Succinct workflows for circulating tumor cells after enrichment: From systematic counting to mutational profiling
por: Wong, Victor Chun-Lam, et al.
Publicado: (2017)

EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
por: Liu, Xiaojie, et al.
Publicado: (2021)

Targeting VEGFR1- and VEGFR2-expressing non-tumor cells is essential for esophageal cancer therapy
por: Xu, Wen Wen, et al.
Publicado: (2014)

RAD50 Loss of Function Variants in the Zinc Hook Domain Associated with Higher Risk of Familial Esophageal Squamous Cell Carcinoma
por: Ko, Josephine Mun Yee, et al.
Publicado: (2021)

The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma
por: Lung, Maria Li, et al.
Publicado: (2014)

HPIP is an essential scaffolding protein running through the EGFR-RAS-ERK pathway and drives tumorigenesis
por: Jiang, Qiwei, et al.
Publicado: (2023)

Potential Chemotherapeutic Effect of Selenium for Improved Canceration of Esophageal Cancer
por: Ahsan, Anil, et al.
Publicado: (2022)

DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation
por: Su, Zhenzi, et al.
Publicado: (2021)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway
por: Yang, Yaqiong, et al.
Publicado: (2021)

Delivery of a chemotherapeutic drug using novel hollow carbon spheres for esophageal cancer treatment
por: Zhang, Li, et al.
Publicado: (2017)

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma
por: Yang, Yuchong, et al.
Publicado: (2019)

Novel Low-Cost Endoscopic Cap for Esophageal Foreign Objects: A Case Report
por: Chiu, King-Wah, et al.
Publicado: (2015)

Bisecting N-Acetylglucosamine on EGFR Inhibits Malignant Phenotype of Breast Cancer via Down-Regulation of EGFR/Erk Signaling
por: Cheng, Lanming, et al.
Publicado: (2020)

Stemness and chemotherapeutic drug resistance induced by EIF5A2 overexpression in esophageal squamous cell carcinoma
por: Yang, Hong, et al.
Publicado: (2015)

Education Attainment, Intelligence and COVID-19: A Mendelian Randomization Study
por: Li, Gloria Hoi-Yee, et al.
Publicado: (2021)

The Combination Options and Predictive Biomarkers of PD-1/PD-L1 Inhibitors in Esophageal Cancer
por: Yang, Hui, et al.
Publicado: (2020)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

Study on chemotherapeutic sensitizing effect of nimotuzumab on different human esophageal squamous carcinoma cells
por: YANG, XIAOYU, et al.
Publicado: (2016)

Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer
por: Chen, Yingjie, et al.
Publicado: (2019)

Niclosamide inhibits the cell proliferation and enhances the responsiveness of esophageal cancer cells to chemotherapeutic agents
por: Lee, Ming-Cheng, et al.
Publicado: (2020)

Computational modelling of cancerous mutations in the EGFR/ERK signalling pathway
por: Orton, Richard J, et al.
Publicado: (2009)

MicroRNA‐338‐5p reverses chemoresistance and inhibits invasion of esophageal squamous cell carcinoma cells by targeting Id‐1
por: Han, Liang, et al.
Publicado: (2019)

Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK
por: Zhao, Guifang, et al.
Publicado: (2023)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Intratumoral PD-1(+)CD8(+) T cells associate poor clinical outcomes and adjuvant chemotherapeutic benefit in gastric cancer
por: Yu, Kuan, et al.
Publicado: (2022)

In Vitro and In Vivo Efficacies of the EGFR/MEK/ERK Signaling Inhibitors in the Treatment of Alveolar Echinococcosis
por: Cheng, Zhe, et al.
Publicado: (2020)

EGFR and ERK activation resists flavonoid quercetin-induced anticancer activities in human cervical cancer cells in vitro
por: Chen, Xin, et al.
Publicado: (2021)

Patients With Short PFS to EGFR-TKIs Predicted Better Response to Subsequent Anti-PD-1/PD-L1 Based Immunotherapy in EGFR Common Mutation NSCLC
por: Liu, Sangtian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0o53vc1s4s5rcp3tqopju74e4l